ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Mental Health Counselor

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,833Medicare Part D Prescriptions Filled, Including Refills
$1.45M Total Retail Price of All Prescriptions
1,416 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
ESCITALOPRAM OXALATE 1,413 1,011 10
TEMAZEPAM 1,307 920 10
ALPRAZOLAM 1,226 790 10
ZOLPIDEM TARTRATE 1,091 626
MIRTAZAPINE 1,052 833
PAROXETINE HCL 989 733 10
TRAZODONE HCL 865 491
LORAZEPAM 727 502 10
SERTRALINE HCL 605 396
CITALOPRAM HBR 592 383
BUPROPION XL 578 329
ABILIFY 560 231
CYMBALTA 555 342
BUPROPION HCL SR 540 318
CLONAZEPAM 539 305 10
FLUOXETINE HCL 489 231
DONEPEZIL HCL 484 451
OLANZAPINE 441 176
LEXAPRO 422 320
BENZTROPINE MESYLATE 372 121 R
SEROQUEL XR 355 167
NAMENDA 320 299
HALOPERIDOL 315 139
RISPERIDONE 236 124
BUSPIRONE HCL 203 97
QUETIAPINE FUMARATE 203 138
LAMOTRIGINE 189 79
DIVALPROEX SODIUM ER 153 39
HYDROXYZINE PAMOATE 151 69 R
VENLAFAXINE HCL ER 148 98
LITHIUM CARBONATE 140 54
TRIFLUOPERAZINE HCL 134 78
SEROQUEL 129 84
FLUPHENAZINE HCL 128 0
DIAZEPAM 89 48
ZYPREXA 88 36
ZIPRASIDONE HCL 86 0
AMITRIPTYLINE HCL 81 69 R
VENLAFAXINE HCL 79 71
RIVASTIGMINE 78 78
PRISTIQ ER 72 55
LUNESTA 71 31
DIVALPROEX SODIUM 69 25
GALANTAMINE HBR 63 63
CLORAZEPATE DIPOTASSIUM 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.